Can-Med Medical Research, Inc.

Victoria, British Columbia V8T 5G1

0 studies enrolling now · 3 studies all time

What they study most

Metastatic Androgen Independent Prostate Cancer, Prostate Cancer, Prostatic Neoplasms

Studies at this site

• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure — Completed